V-CILLIN K Drug Patent Profile

When do V-cillin K patents expire, and what generic alternatives are available?

V-cillin K is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in V-CILLIN K is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for V-cillin K

A generic version of V-CILLIN K was approved as penicillin v potassium by CHARTWELL RX on November 23^rd, 1988.

Summary for V-CILLIN K

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	65
Patent Applications:	1,664
DailyMed Link:	V-CILLIN K at DailyMed

US Patents and Regulatory Information for V-CILLIN K

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	V-CILLIN K	penicillin v potassium	FOR SOLUTION;ORAL	060004-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	V-CILLIN K	penicillin v potassium	TABLET;ORAL	060003-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	V-CILLIN K	penicillin v potassium	FOR SOLUTION;ORAL	060004-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	V-CILLIN K	penicillin v potassium	TABLET;ORAL	060003-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lilly	V-CILLIN K	penicillin v potassium	TABLET;ORAL	060003-003	Approved Prior to Jan 1, 1982		DISCN	No	No